Skip to main content
Premium Trial:

Request an Annual Quote

MOgene Providing Services Based on Lawrence Livermore National Laboratory's Array

NEW YORK (GenomeWeb News) – Genomics service provider MOgene today said it has signed an agreement with Lawrence Livermore National Laboratory to provide services using the Lawrence Livermore Microbial Detection Array.

The array probes for more than 3,000 bacterial and viral species and has been optimized for NimbleGen arrays, said MOgene, a NimbleGen service provider. The array provides rapid and comprehensive analysis of bacteria and viruses from biological material of unknown nature, and has been shown to be of use in food and pharmaceutical safety, detection of bacterial and viral infections, animal health, and other applications, the St. Louis-based firm said.

It added that the array would allow food safety professionals, law enforcement, medical professionals, and others to detect any virus or bacteria that has been sequenced and included among the arrays' probes within 24 hours.

Shaukat Rangwala, senior vice president of MOgene, said in a statement that the deal "allows us to expand into new areas for our microarray and sequencing service business."

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.